Moore Capital Management’s CureVac CVAC Stock Holding History

Moore Capital Management’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-111,100	Closed	-$759K	–	468
2023 Q3	$759K	Buy	+111,100	New	+$981K	0.01%	315

Other funds holding CVAC

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Moore Capital Management's CVAC Position: Q4 2020 in Review

Moore Capital Management sold out of CureVac (CVAC) in Q4 2020, closing a stake of 20,967 shares — an estimated $976K sold.

Moore Capital Management first reported a position in CVAC in Q3 2020 and held it in 1 quarter. The position peaked at $976K in Q3 2020. 61 funds tracked by Wall St. Rank hold CVAC as of Q4 2020.

Moore Capital Management reported no remaining CureVac position as of Q4 2020 after selling out during the quarter.
Moore Capital Management sold 20,967 CureVac shares in Q4 2020, an estimated $976K.
Moore Capital Management first reported a position in CureVac in Q3 2020 and held it in 1 quarter.
Moore Capital Management's CureVac position peaked at $976K in Q3 2020.
61 funds tracked by Wall St. Rank held CureVac as of Q4 2020.

Based on Moore Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.